181 related articles for article (PubMed ID: 15094711)
21. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
22. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
[TBL] [Abstract][Full Text] [Related]
23. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus.
Bansal A; McGregor DH; Anand O; Singh M; Rao D; Cherian R; Wani SB; Rastogi A; Singh V; House J; Jones PG; Sharma P
Dis Esophagus; 2014; 27(8):751-6. PubMed ID: 24165297
[TBL] [Abstract][Full Text] [Related]
24. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
25. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?
Zhang W; Wang DH
Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Analysis of Barrett's Esophagus: Focused on Carcinogenic Potential for Barrett's Cancer in Japanese Patients.
Ishikawa K; Okimoto K; Matsumura T; Hirotsu Y; Amemiya K; Kishimoto T; Akizue N; Ohta Y; Saito K; Maruoka D; Nishimura M; Matsushita K; Mochizuki H; Arai M; Kato J; Yokosuka O; Omata M; Kato N
Dig Dis Sci; 2021 Aug; 66(8):2674-2681. PubMed ID: 32840705
[TBL] [Abstract][Full Text] [Related]
27. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk.
Kelty CJ; Gough MD; Van Wyk Q; Stephenson TJ; Ackroyd R
Scand J Gastroenterol; 2007 Nov; 42(11):1271-4. PubMed ID: 17852872
[TBL] [Abstract][Full Text] [Related]
28. Changing role of in vivo models in columnar-lined lower esophagus.
Koak Y; Winslet M
Dis Esophagus; 2002; 15(4):271-7. PubMed ID: 12472470
[TBL] [Abstract][Full Text] [Related]
29. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma in columnar-lined Barrett's esophagus. Analysis of 13 esophagectomies.
Saubier EC; Gouillat C; Samaniego C; Guillaud M; Moulinier B
Am J Surg; 1985 Sep; 150(3):365-9. PubMed ID: 4037198
[TBL] [Abstract][Full Text] [Related]
31. Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.
van der Woude CJ; Jansen PL; Tiebosch AT; Beuving A; Homan M; Kleibeuker JH; Moshage H
Hum Pathol; 2002 Jul; 33(7):686-92. PubMed ID: 12196918
[TBL] [Abstract][Full Text] [Related]
32. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.
Sato T; Miwa K; Sahara H; Segawa M; Hattori T
Anticancer Res; 2002; 22(1A):39-44. PubMed ID: 12017320
[TBL] [Abstract][Full Text] [Related]
33. Short and ultrashort Barrett's esophagus--what does it mean?
Spechler SJ
Semin Gastrointest Dis; 1997 Apr; 8(2):59-67. PubMed ID: 9109693
[TBL] [Abstract][Full Text] [Related]
34. Columnar lined oesophagus and intestinal metaplasia: current concepts.
Wolf C; Timmer R; Breumelhof R; Seldenrijk CA; Smout AJ
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):793-800. PubMed ID: 10445803
[TBL] [Abstract][Full Text] [Related]
35. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy.
O'Riordan JM; Tucker ON; Byrne PJ; McDonald GS; Ravi N; Keeling PW; Reynolds JV
Am J Gastroenterol; 2004 Feb; 99(2):205-11. PubMed ID: 15046206
[TBL] [Abstract][Full Text] [Related]
37. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model.
Clark GW; Smyrk TC; Mirvish SS; Anselmino M; Yamashita Y; Hinder RA; DeMeester TR; Birt DF
Ann Surg Oncol; 1994 May; 1(3):252-61. PubMed ID: 7842295
[TBL] [Abstract][Full Text] [Related]
38. Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model.
Kumagai H; Mukaisho K; Sugihara H; Bamba M; Miyashita T; Miwa K; Hattori T
Scand J Gastroenterol; 2003 Jul; 38(7):687-92. PubMed ID: 12889552
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus.
Glickman JN; Chen YY; Wang HH; Antonioli DA; Odze RD
Am J Surg Pathol; 2001 May; 25(5):569-78. PubMed ID: 11342767
[TBL] [Abstract][Full Text] [Related]
40. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
